Package 13913-012-03

{"route": ["ORAL"], "spl_id": "b9a3d927-3dc3-4860-ac3b-3dd20df47dd6", "openfda": {"unii": ["L4D5UA6CB4"], "rxcui": ["859063", "859066"], "spl_set_id": ["d249ced1-4ca0-4f57-adcb-23440f58f659"], "manufacturer_name": ["Assertio Therapeutics, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "9 PACKET in 1 CARTON (13913-012-02)  / 1 POWDER, FOR SOLUTION in 1 PACKET", "package_ndc": "13913-012-02", "marketing_start_date": "20160310"}, {"sample": false, "description": "9 PACKET in 1 CARTON (13913-012-03)  / 1 POWDER, FOR SOLUTION in 1 PACKET (13913-012-01)", "package_ndc": "13913-012-03", "marketing_start_date": "20160310"}], "brand_name": "Cambia", "product_id": "13913-012_b9a3d927-3dc3-4860-ac3b-3dd20df47dd6", "dosage_form": "POWDER, FOR SOLUTION", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "13913-012", "generic_name": "diclofenac potassium", "labeler_name": "Assertio Therapeutics, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cambia", "active_ingredients": [{"name": "DICLOFENAC POTASSIUM", "strength": "50 mg/1"}], "application_number": "NDA022165", "marketing_category": "NDA", "marketing_start_date": "20160310", "listing_expiration_date": "20261231"}